John Meady

NYSE Movers: Oracle Corporation (NYSE:ORCL), Vale (NYSE:VALE), Ford Motor Company (NYSE:F), Bank of America Corp (NYSE:BAC), Coach Inc (NYSE:COH)

Oracle Corporation (NYSE: ORCL) has agreed to buy Micros Systems Inc (NASDAQ: MCRS) for $5.3 billion. Chief Executive Officer, Larry Ellison seeks to boost its slowing growth by expanding into hospitality and retail industries.   Oracle Corporation (NYSE:ORCL) stock performance was 0.69% in last session and finished the day at $41.10. Traded volume was 16.96million shares in the…

Read More

Small Cap Losers: Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Altisource Asset Management (NYSEMKT:AAMC), Oncomed Pharmaceuticals (NASDAQ:OMED), Agios Pharmaceuticals (NASDAQ:AGIO)

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that data from a Phase 1 study of the selective estrogen receptor modulator (SERM) lasofoxifene were featured in a poster presentation today at ICE/ENDO 2014 in Chicago.  Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) stock performance was -5.92% in last session and finished the day at $62.35. Traded volume was 400.60K shares…

Read More

Bullish Stocks at NASDAQ: BlackBerry Ltd (NASDAQ:BBRY), Abraxas Petroleum (NASDAQ:AXAS), Yandex NV (NASDAQ:YNDX), ISIS Pharmaceuticals (NASDAQ:ISIS), Hanwha Solarone (NASDAQ:HSOL)

Blackberry Ltd. (NASDAQ:BBRY) has announced the release of a weird new rectangle that is supposed to be some kind of phone, that they call the “Passport.” Joining the race in “phablet” market a little late in the game, the former tech giant is hoping to foster renewed interest in their, primarily business, market structure. BlackBerry…

Read More

Health Stocks to Watch: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Eli Lilly (NYSE:LLY)

Earlier this month, Vivus Inc. (NASDAQ:VVUS) said it filed a patent-infringement lawsuit against Actavis PLC ( ACT ) alleging that the drug maker’s planned generic version of weight-loss drug Qsymia infringes its patents. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 3.97% in last session and finished the day at $5.50. Traded volume was 4.47million shares in the last…

Read More